Matt Callahan

Matt Callahan is a Perth-raised biotechnology executive currently based in Pennsylvania, USA. He is an executive director at ASX-listed Botanix Pharmaceutical and unlisted company Respirion Pharmaceutical. Mr Callahan remains a partner at Stone Ridge Ventures, a seed stage venture capital fund based in Perth. He won a 40under40 award as as the business development director of QPSX. Mr. Callahan has a Bachelor of Laws (Honours) from the University of WA and an MBA.
Bio last updated 16 Nov 2019

Article Timeline

Network Graph

Displaying all related organisations and their related contacts. Hover over a node to display a link to the BNiQ page for that person or organisation.

Access to our data for Matt Callahan is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Matt Callahan is linked to 8 organisations which are included in 1 list - Fund Managers.

To see the data you will need to .


Executive Director
Executive Director
Partner, Investment Director since 2007
Year started and most recent title

Share Transactions

$0 Other
$10k Issued
$1.1m Sold
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer